» Articles » PMID: 31666265

Bacterial Antibiotic Resistance Development and Mutagenesis Following Exposure to Subminimal Inhibitory Concentrations of Fluoroquinolones in Vitro: a Systematic Literature Review Protocol

Overview
Journal BMJ Open
Specialty General Medicine
Date 2019 Nov 1
PMID 31666265
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Antibiotic resistance (AR) is among the most pressing global health challenges. Fluoroquinolones are a clinically important group of antibiotics that have wide applicability in both humans and animals. While many drivers of AR are known, the impact of medicine quality on AR remains largely unknown. The aim of this review is to systematically evaluate the evidence of the impact of in vitro subinhibitory antibiotic exposure, a major tenet of substandard antibiotics, on the development of AR and mutagenesis, using fluoroquinolones as a case study.

Methods And Analysis: EMBASE, Web of Science and PubMed will be systematically searched for primary experimental in vitro studies, from earliest available dates within each database (1947, 1965 and 1966, respectively) through 2018, related to subinhibitory fluoroquinolone exposure and AR. A specifically developed non-weighted tool will be used to critically assess the evidence. Subgroup analyses will be performed for different variables and outcomes.

Ethics And Dissemination: Ethical approval is not required as no primary data are to be collected. The completed systematic review will be disseminated through conference meeting presentations and a peer-reviewed publication.

Citing Articles

Aquatic Environments as Hotspots of Transferable Low-Level Quinolone Resistance and Their Potential Contribution to High-Level Quinolone Resistance.

Miranda C, Concha C, Godoy F, Lee M Antibiotics (Basel). 2022; 11(11).

PMID: 36358142 PMC: 9687057. DOI: 10.3390/antibiotics11111487.


Bacterial antibiotic resistance development and mutagenesis following exposure to subinhibitory concentrations of fluoroquinolones : a systematic review of the literature.

Ching C, Orubu E, Sutradhar I, Wirtz V, Boucher H, Zaman M JAC Antimicrob Resist. 2021; 2(3):dlaa068.

PMID: 34223024 PMC: 8210091. DOI: 10.1093/jacamr/dlaa068.


Quinolones: Mechanism, Lethality and Their Contributions to Antibiotic Resistance.

Bush N, Diez-Santos I, Abbott L, Maxwell A Molecules. 2020; 25(23).

PMID: 33271787 PMC: 7730664. DOI: 10.3390/molecules25235662.


Development and selection of low-level multi-drug resistance over an extended range of sub-inhibitory ciprofloxacin concentrations in Escherichia coli.

Ching C, Zaman M Sci Rep. 2020; 10(1):8754.

PMID: 32471975 PMC: 7260183. DOI: 10.1038/s41598-020-65602-z.


Evaluation of Thio- and Seleno-Acetamides Bearing Benzenesulfonamide as Inhibitor of Carbonic Anhydrases from Different Pathogenic Bacteria.

Angeli A, Pinteala M, Maier S, Simionescu B, Milaneschi A, Abbas G Int J Mol Sci. 2020; 21(2).

PMID: 31963423 PMC: 7014678. DOI: 10.3390/ijms21020598.

References
1.
Zhanel G, Kim S, Davidson R, Hoban D, Nicolle L . Effect of subinhibitory concentrations of Ciprofloxacin and gentamicin on the adherence of Pseudomonas aeruginosa to Vero cells and voided uroepithelial cells. Chemotherapy. 1993; 39(2):105-11. DOI: 10.1159/000239110. View

2.
Chatterjee A, Modarai M, Naylor N, Boyd S, Atun R, Barlow J . Quantifying drivers of antibiotic resistance in humans: a systematic review. Lancet Infect Dis. 2018; 18(12):e368-e378. DOI: 10.1016/S1473-3099(18)30296-2. View

3.
van der Putten B, Remondini D, Pasquini G, Janes V, Matamoros S, Schultsz C . Quantifying the contribution of four resistance mechanisms to ciprofloxacin MIC in Escherichia coli: a systematic review. J Antimicrob Chemother. 2018; 74(2):298-310. DOI: 10.1093/jac/dky417. View

4.
Macguire A, Ching M, Diamond B, Kazakov A, Novichkov P, Godoy V . Activation of phenotypic subpopulations in response to ciprofloxacin treatment in Acinetobacter baumannii. Mol Microbiol. 2014; 92(1):138-52. PMC: 4005408. DOI: 10.1111/mmi.12541. View

5.
Okeke I, Klugman K, Bhutta Z, Duse A, Jenkins P, OBrien T . Antimicrobial resistance in developing countries. Part II: strategies for containment. Lancet Infect Dis. 2005; 5(9):568-80. DOI: 10.1016/S1473-3099(05)70217-6. View